Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
1997514 citationsD. Caillot, Olivier Casasnovas et al.Journal of Clinical Oncologyprofile →
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
2017392 citationsPhilip L. McCarthy, Sarah A. Holstein et al.Journal of Clinical Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of D. Caillot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Caillot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Caillot more than expected).
This network shows the impact of papers produced by D. Caillot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Caillot. The network helps show where D. Caillot may publish in the future.
Co-authorship network of co-authors of D. Caillot
This figure shows the co-authorship network connecting the top 25 collaborators of D. Caillot.
A scholar is included among the top collaborators of D. Caillot based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D. Caillot. D. Caillot is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
McCarthy, Philip L., Sarah A. Holstein, Maria Teresa Petrucci, et al.. (2017). Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis. Journal of Clinical Oncology. 35(29). 3279–3289.392 indexed citations breakdown →
Caillot, D., Olivier Casasnovas, Alain Bernard, et al.. (1997). Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.. Journal of Clinical Oncology. 15(1). 139–147.514 indexed citations breakdown →
Hennequin, Christophe, M. Rabodonirina, A. Datry, et al.. (1997). Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO.. PubMed. 35(2). 107–14.35 indexed citations
Brichon, Pierre-Yves, et al.. (1989). [Extramedullary pancreatic localization of myeloma].. PubMed. 140(5). 421–2.1 indexed citations
13.
Goudet, Pierre, et al.. (1988). [Retrospective echographic surveillance of a population of patients splenectomized for hematologic reasons. Thrombosis of the portal vein is rare].. PubMed. 114(5). 383–6.4 indexed citations
14.
Chagué, F., C Sgro, D. Caillot, et al.. (1987). [Agranulocytosis caused by cinepazide maleate. 2 case reports].. PubMed. 42(1). 67–67.1 indexed citations
15.
Guy, H., et al.. (1987). [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].. PubMed. 16(43). 2172–5.2 indexed citations
16.
Chavanet, P., et al.. (1987). [Treatment of bacterial infections by ofloxacin. 42 cases].. PubMed. 35(5). 620–3.1 indexed citations
17.
Bonnin, Alain, et al.. (1985). Périhépatite et maladie lupique. La Revue de Médecine Interne. 6(3). 301–302.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.